Article
Transient antiretroviral therapy selecting for common HIV-1 mutations substantially accelerates the appearance of rare mutations.
Theoretical biology & medical modelling - 14 Nov 2008
Shiri Tinevimbo, Welte Alex
Abstract excerpt
BACKGROUND: Highly selective antiretroviral (ARV) regimens such as single dose nevirapine (NVP) used for prevention of mother to child transmission (PMTCT) in resource-limited settings produce transient increases in otherwise marginal subpopulations of cells infected by mutant genomes. The longer...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
